Microbial and Bacterial Cellulose Production Market Size To Reach USD 980.9 Million By 2028 | Top Key Players Celluforce, American Process, Axcelon Biopolymers Corporation

Favorable funding from private as well as public firms, increasing end-use applications in biomedical field, and increasing R&D investments in the healthcare sector are likely to fuel the market growth.

According to the current analysis of Reports and Data, the global Microbial and Bacterial Cellulose Production Market was valued at USD 506.8 Million in 2020 and is expected to reach USD 980.9 Million by 2028, at a CAGR of 8.1%. Wide application of microbial and bacterial cellulose in wound care, therapeutics, cosmetology, cardiovascular diseases, oncology, ophthalmology, urology, drug delivery systems, tissue engineering, and tissue regeneration are expected to propel market growth over the forecast period

According to the International Journal of Biological Macromolecules, bacterial cellulose (BC) has sparked a lot of interest in the pharmaceutical and medical fields because of its inherent physical, mechanical, and biological properties. BC was first used in artificial blood vessel development, organ development, tissue regeneration, and wound dressing. According to the International Journal of Biological Macromolecules, multiple BC-based composite scaffolds have been developed and are used in the treatment of cancer. According to Canada's Health Fact Sheets Diabetes, 2.3 million Canadians were diagnosed with diabetes in 2017. BC can help to improve human health by replacing these fats. The US Food and Drug Administration (FDA) has declared bacterial cellulose (BC) to be a "Generally Recognized as Safe" (GRAS) food. Bacterial cellulose is used as a dietetic food for humans because of its fibre content, which makes it easier to digest. Nata-de-coco, a bacterial cellulose grown from coconut water with amino acids and carbohydrates, is one of the most well-known BC.

Asia Pacific region is expected to register highest CAGR of 8.5% over the forecast period. Several market players are relocating their manufacturing facilities to Asia Pacific as a result of favorable government policies, the availability of low-cost labor, and rising demand for bacterial cellulose in the region's food and beverage industry. However, the availability of substitutes and strict regulations are likely to restrain market growth.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/4012

Market Overview:

The pharma and healthcare industry has undergone a revolutionary change owing to the COVID-19 pandemic with individuals increasing their focus on health and wellness. Companies operating in the industry have invested heavily in clinical trials and research studies to develop medications to cater to the growing unmet clinical demand on a global level. Implementation of cutting-edge technology in healthcare sector and increasing investment in research and development have contributed significantly to revenue growth of the market in the recent past. In addition, availability of favorable health insurance and reimbursement policies have also positively impacted the healthcare sector with more and more individuals opting to get treatment at hospital and clinical facilities. Rapid development of novel drugs and pharmaceuticals, increasing incidence of lifestyle and chronic diseases, establishment of state-of-the-art healthcare facilities, and rising availability of over-the-counter medications have significantly contributed to the revenue growth of the market.

The report has gather vital information about recent mergers and acquisitions, joint ventures, collaborations, partnerships, brand promotions, R&D activities, and government and corporate deals, among others through extensive primary and secondary research. The report also offers detailed analysis of each competitor along with their financial standing, global market position, product portfolio, manufacturing and production capacity, and business expansion plans.

The report offers a comprehensive overview of the regional bifurcation of the market with respect to market share, market size, revenue growth, import/export, production and consumption patterns, macro and micro economic growth factors, regulatory framework, investment and funding opportunities, and presence of key players in each region including North America, Asia Pacific, Latin America, Europe, and Middle East & Africa. The report offers a country-wise analysis to further discuss the revenue growth and lucrative growth opportunities for the Microbial and Bacterial Cellulose Production market in these key regions.

Further key findings from the report suggest

• Based on the growth media, synthetic media segment accounted for the largest market share of 57.5% in 2020. The most well-known synthetic method for growing bacterial cellulose is the Hestrin–Schramm (HS) medium. An ideal synthetic medium contains glucose, ammonium sulfate, monopotassium phosphate, disodium phosphate, magnesium sulfate, nicotinamide, and ethanol.

• Among bacteria type, gram negative bacteria segment accounted for the significant share in the forecast period. Secretion of large amounts of cellulose as micro-fibrils from Gluconacetobacter xylinus is likely boost market growth.

• In December 2020, Borregaard has received a commitment of NOK 15.7 million in funding from the Research Council of Norway for a project for the development of biochemicals to replace petrochemical alternatives.

• North America, registered largest share of approximately, 37.8% in the Microbial and Bacterial Cellulose Production market attributing to well-developed healthcare infrastructure, increasing investments by major players in R&D, and growing applications of bacterial cellulose in wound care products.

• Key players in the market include Celluforce, American Process, Axcelon Biopolymers Corporation, Borregaard, Bowil Sp. z o. o., Daicel Corporation, Fzmb GmbH, Merck KGaA, Nippon Paper Industries Co., Ltd., and Nympheas International Biomaterial Corporation.

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/4012

For the purpose of this study, Reports and Data have segmented Microbial and Bacterial Cellulose Production market on the basis of Growth Medium, Production Method, Bacteria Type, Application and Region:

Growth Medium Outlook (Revenue in Million USD; 2018–2028)

• Synthetic Media
• Non-Synthetic Media

Mode of Delivery Outlook (Revenue in Million USD; 2018–2028)

• Static Method
• Dynamic Method

Bacteria Type Outlook (Revenue in Million USD; 2018–2028)

• Gram Negative Bacteria
o Agrobacterium tumefaciens
o Rhizobium
o Aerobacter
o Azotobacter
o Others
• Gram Positive Bacteria

Application Outlook (Revenue in Million USD; 2018–2028)

• Pharmaceutical And Medical Applications
o Wound Care Therapeutics
o Cosmetology
o Cardiovascular Diseases
o Oncology
o Ophthalmology
o Urology
o Drug Delivery Systems
o Tissue Engineering And Regeneration
o Other Antimicrobial Products
• Non-Medical Application
o Food Industry
o Paper Industry
• Others

Regional Outlook (Revenue in Million USD; 2018–2028)

• North America
• Europe
• Asia Pacific
• Middle East & Africa
• Latin America

Additionally, the report consists a detailed analysis of the segmentation of the Microbial and Bacterial Cellulose Production market based on product types and end-use/application offered in the Microbial and Bacterial Cellulose Production market.

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/4012

Thank you for reading our report. For customization inquiry or further information, please connect with us and we will ensure you get the report that meets your requirements.

Read More Reports:-

Transplant Diagnostics Market @ https://www.biospace.com/article/transplant-diagnostics-market-size-to-reach-usd-7-08-billion-in-2028-says-reports-and-data/

Zika Virus Testing Market @ https://www.biospace.com/article/zika-virus-testing-market-to-reach-usd-328-3-million-in-2028-says-reports-and-data/

C-Reactive Protein Testing Market @ https://www.biospace.com/article/c-reactive-protein-testing-market-size-to-reach-usd-1-93-billion-in-2028-says-reports-and-data-/

Contact Us:

John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

This release was published on openPR.